Geneferm Biotechnology Co. Ltd. · TPEX:1796
Geneferm Biotechnology — Investor Conference (December 2025)
27 slides from Geneferm Biotechnology's conference presentation, Dec 19, 2025
Slide 1: Investor Conference
GeneFerm Biotechnology Co., Ltd.(1796) Investor Conference 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 2: 免責聲明 Safe Harbor Notice
免責聲明 Safe Harbor Notice 本次簡報與討論包含特定預測性的說明，而其內容有關於營運結果、財務狀況，以及對未來 事件的預期。因為此等前瞻性說明是有關於未來事件，而且取決於未來發生時的環境因素， 所以必然含有風險與不確定性。 本公司將不負擔公開更新或修改這些預測性的說明之義務，無論是出現新資訊、未來發生任 何事件，或其他情況。實際結果可能與此等預測性說明推測的內容有重大差異。 In these presentations and discussions, here are certain forward looking statements regarding the resu
Slide 3: Contents
CONTENTS Company Profile Operational Overview Precision fermentation ESG 3 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 4: Company Profile
Company Profile Date of establishment: July 17, 1999 Share capital: 414,598 NTD Chairman of the board: Grace Chang Number of employees: 288 Production base: Main business: Southern Taiwan Science Park: Application of biotechnology in food, Plant I : No.3, Dali 2nd Rd., Shanhua Dist., branded product
Slide 5: Company History
Company History Expanded three sets of STSP plant I was opened drying equipment at STSP plant I Set up Two sets of 50,000L fermenters are activated diversified liquid filling equipment in GMP certified Fermentation toll Establish GHP certified Company Biggest fermentation Xinying plant (Capsule, LQ,
Slide 6: Headquarter and production sites
Taipei Sales Office Nangang Software Park Southern Taiwan Science Park Xinying Factory Dongguan Office Supplement filling, Headquarter packaging Fermentation, Extraction • Capsule Toll manufacturing • Jelly • Powder sachet • CDMO • Liquid / Drink • Raw material production • Tablet 6 6 「本資料僅供內部教育訓練課程
Slide 7: Core Technology
Core Technology R & D Research Growth Optimization • Microbial database preservation • Screening of optimal strains • Functional product design • Media Composition • Natural substance exploration • Optimizing Growth Parameters Production Process development • 66-ton scale fermentation mass • Culture
Slide 8: Operating projects
Operating projects International Health food Professional raw materials Fermentation CDMO OEM/ODM services GeneFerm private for functional dietary label products supplements 8 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 9: STSP Plant I - Biomass Fermentation
STSP Plant I - Biomass Fermentation Extraction and Fermentation Equipment Quantity Specification concentration equipment Extractor 50,000 L 50-55,000 L Liquid-State Fermenter Extraction condenser tank 200-15,000 L Total：240,000 L HACCP FSSC22000 Continuous Vacuum Evaporator (1,000 L / hr) 1 Solid-St
Slide 10: STSP Plant II - Precision Fermentation
STSP Plant II -Precision Fermentation Fermentation equipment Specification Solid-liquid separation equipment 80-66,000 L Continuous Disk Stack Auto-Cleaning Membrane Filter Press Liquid-State Fermenter Centrifuge (Filtration area 36 m2 /100 m2 ) Total：158,720 L HACCP FSSC22000 Purification equipment
Slide 11: Xinying Factory: One-stop OEM/ODM service
Xinying Factory: One-stop OEM/ODM service Tablet ( Oral/Time-released Sachet ( Powder/Granule ) Capsule ( Gelatin/Vegan ) /Chewable ) GMP HACCP FSSC 22000 Liquid Jelly Jelly drink Multi-dosage form production line 11 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 12: Patents and International Invention Awards
Patents and International Invention Awards Advanced R&D Excellence Supported by Global Patents Winner of Multiple Global Invention Awards 19 12 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 13: Global-Scale Manufacturing & Worldwide Marketing
Global-Scale Manufacturing & Worldwide Marketing 1,000+ Global Partners 13 13 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 14: Contents
CONTENTS Company Profile Operational Overview Precision fermentation ESG 14 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 15: Operational Overview
Operational Overview Unit：Thousands of NTD Comparison of the first three quarters of 2025/2024 Q1~Q3_2025 Q1~Q3_2024 Project/Year YoY Amount % Amount % Revenue 499,886 100% 366,170 100% 36.5% Gross profit 134,374 27% 67,894 18% 97.9% Operating expenses (107,144) -22% (96,220) -26% Operating gain (lo
Slide 16: Revenue and gross profit margin in the past three years and 2025
Revenue and gross profit margin in the past three years and 2025 Revenue 營業額(仟元) Gross 毛利率Profit Margin (in thousands) 793,770 800,000 40% 700,000 35% 615,229 633,963 Unaudited financial results 600,000 499,886 30% 521,163 500,000 25% 400,000 20% 300,000 15% 200,000 10% 100,000 5% - 0% 2022 2023 202
Slide 17: Revenue Categories Annual
Revenue Breakdown for the Past Three Years and 2025 Unit: NT$1,000 Revenue 2022 2023 2024 Q1~Q3_2025 Categories Annual Amount % Amount % Amount % Amount % Health food 467,604 74% 459,218 58% 417,039 80% 350,834 70% revenue OEM revenue 165,021 26% 325,678 41% 102,827 20% 146,739 29% Other 1,338 - 8,8
Slide 18: Contents
CONTENTS Company Profile Operational Overview Precision fermentation ESG 14 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 19: Precision Fermentation
Precision Fermentation Using microorganisms such as yeast or bacteria, genetic engineering techniques are applied to enable them to produce the desired target molecules. These microorganisms are then massively cultured through fermentation, turning them into “micro-factories” for producing the targe
Slide 20: Application Industry
Application Industry Mass Production Food Cosmetics Mass Production Biomaterials • Lactoglobulin Nutrition • Collagen • Casein • Bio-squalene • Hyaluronic acid • Vitamins • Biodegradable plastics • Recombinant collagen Pharma • Functional peptides • Human milk Chemicals • Spider silk protein oligosa
Slide 21: Global Market Size
Global Market Size 2024 Market Size CAGR (Compound Projected size in (USD) Annual Growth Rate) 2030 (USD) $3-4B 10-15% $8-10B Food + Industrial Enzymes Continued growth is Growth drivers: + Biotechnology expected until 2030. sustainability, de-animalization 21 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 22: Core Advantages of GeneFerm Biotechnology
Core Advantages of GeneFerm Biotechnology Vertical Integrated Technology Platform Economies of Scale & Asset Barriers Pilot Verification → Fermentation Scale-Up → DSP • Precision fermentation capacity up to 158,720 L High-Performance Purification • Sufficient commercial-grade production capacity Pro
Slide 23: Contents
CONTENTS Company Profile Operational Overview Precision fermentation ESG 14 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
Slide 24: Precision Fermentation – Sustainability Highlights
Precision Fermentation – Sustainability Highlights Social Supports Vegan, Halal, Environment Kosher, and animal-free Governance diets. Traceable and controllable Reduces carbon emissions, bioprocesses with land, and water usage, international certification enhancing raw material management, reducing
Slide 25: 2024 Sustainability Report
2024 Sustainability Report 1 Corporate • Board directors receive at least 6 hours of annual continuing education. • Annual self-evaluation of the Board of Directors and functional committees is conducted; Governance every three years, an external professional institution evaluates Board performance.
Slide 26: 2024 Sustainability Report
2024 Sustainability Report 4 Health & Workplace • Complies with labor regulations and supports international human rights conventions, safeguarding human rights and fostering a fair and friendly work environment. 5 Social • We actively fulfill our corporate social responsibility and practice corpora
Slide 27: Q&A
Q&A 「本資料僅供內部教育訓練課程運用，嚴禁運用於行銷推廣
GeneFerm Biotechnology — Investor Conference (December 2025) on 6ix